Holdings (34)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 12.4402776% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 8.57494518% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 6.91203054% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.79613378% |
| Cipla Ltd. | Healthcare | Equity | 5.55292875% |
| Lupin Ltd. | Healthcare | Equity | 5.22777262% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.34292905% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 4.23720429% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 4.2211304% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 3.45921695% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 1.46% | 22.22% | 16.93% | 27.87% |
| Category Average | -2.14% | 22.11% | 14.61% | NA% |
| Rank Within Category | 9.00% | 5.00% | 2.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 0.48%
Inclusive of GST
Exit load
Exit load of 1% if redeemed within 1 year.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Kasera is a MBA (Finance), CFA (ICFAI).
Experience
Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.
Managed Schemes
Education
B.Com, C.A.
Experience
Prior to joining the Mirae asset MF, he was associated with SBI capital markets.